**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 15629-92-2 |[1,3-Bis(Diphenylphosphino)Propane]Nic| ca. 100 | unlisted |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 36/37/38 40 42/43
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin. Limited evidence of
a carcinogenic effect. May cause sensitization by inhalation and skin
contact.The toxicological properties of this material have not been
fully investigated.Cancer suspect agent.Moisture sensitive.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. The toxicological properties of this substance have not
been fully investigated.
Inhalation:
Causes respiratory tract irritation. The toxicological properties of
this substance have not been fully investigated. Inhalation of dust
may cause respiratory tract irritation.
Chronic:
May cause cancer according to animal studies. Symptoms of
overexposure to nickel can cause sensitization, dermatitis, allergic
asthma and pneumonitis.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.
Antidote:
None reported.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Do NOT get water
inside containers. Use water spray, dry chemical, carbon dioxide, or
appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up or absorb material, then place into a
suitable clean, dry, closed container for disposal. Avoid generating
dusty conditions. Provide ventilation. Do not get water inside
containers.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use only in a well-ventilated area.
Minimize dust generation and accumulation. Avoid contact with eyes,
skin, and clothing. Keep container tightly closed. Avoid ingestion
and inhalation. Use with adequate ventilation. Do not allow contact
with water. Wash clothing before reuse. Keep from contact with moist
air and steam.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Store
protected from moisture.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local exhaust ventilation to keep airborne concentrations below the
permissible exposure limits.
Exposure Limits
CAS# 15629-92-2:
United States OSHA: 1 mg/m3 TWA (as Ni) (listed under Nickel sol
compounds).
Belgium - TWA: (listed as nickel soluble compounds): 0.1 mg/m3 VL
(as Ni)
Malaysia: (listed as nickel soluble compounds): 0.1 mg/m3 TWA
(inhalable fraction, as Ni)
Netherlands: (listed as nickel soluble compounds): 0.1 mg/m3 MAC
Ni)
Spain: (listed as nickel soluble compounds): 0.1 mg/m3 VLA-ED (as
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use. Follow the OSHA
respirator regulations found in 29 CFR 1910.134 or
European Standard EN 149. Use a NIOSH/MSHA or
European Standard EN 149 approved respirator if
exposure limits are exceeded or if irritation or
other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: red-orange
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 213 deg C dec
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C27H26Cl2NiP2
Molecular Weight: 542.04
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions. Thermal decomposition may produce toxic
fumes of phosphorous oxides and/or phosphine.
Conditions to Avoid:
Incompatible materials, dust generation, moisture, excess heat,
exposure to moist air or water.
Incompatibilities with Other Materials:
Moisture.
Hazardous Decomposition Products:
Hydrogen chloride, carbon monoxide, oxides of phosphorus, carbon
dioxide, nickel oxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 15629-92-2 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
[1,3-Bis(Diphenylphosphino)Propane]Nickel(II) Chloride -
California: carcinogen, initial date 5/7/04 (listed as Nickel compound
NTP: Known carcinogen (listed as Nickel compounds).
IARC: Group 1 carcinogen (listed as Nickel compounds).
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
R 40 Limited evidence of a carcinogenic effect.
R 42/43 May cause sensitization by inhalation and
skin contact.
Safety Phrases:
S 22 Do not breathe dust.
S 24 Avoid contact with skin.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 15629-92-2: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 15629-92-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 15629-92-2 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 4/27/1999 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
3-Ethylaniline, 98%
| 587-02-0 |
|
Hydroxypropyl-Betha-Cyclodextrin, 97+% (TLC), (on the dry substance)
| 94035-02-6 |
|
4-Chloro-3-nitrophenyl cyclopropyl ketone, 99+%
| 31545-26-3 |
|
Acetonitrile-D3, 100.0 Atom % D
| 2206-26-0 |
|
Bromopentafluorobenzene, 99%
| 344-04-7 |
|
Normal-Propyl Sulfoxide, Tech.
| 0-01-1 |
|
p-Toluenesulfinic Acid, Sodium Salt, 98+% Hydrate
| 824-79-3 |
|
2-Acetylbutyrolactone, 99+%
| 517-23-7 |
|
Formamidine Disulfide Dihydrochloride, 94%
| 14807-75-1 |
|
4,4'-Dichloro-alpha-methylbenzhydrol, 99%
| 80-06-8 |
|
3-O-Methylglucose, 99%
| 13224-94-7 |
|
Mithramycin, 90% (HPLC)
| 18378-89-7 |
|
Phosphorus pentasulfide, 98+%
| 1314-80-3 |
|
5-Hydroxymethyl-5-methyl-1,3-dioxane, 97%
| 1121-97-7 |
|
2,3,5-Triiodobenzoic Acid, 98%
| 88-82-4 |
|
n-Methylbutylamine, 98% (GC)
| 110-68-9 |
|
Quinacrine dihydrochloride dihydrate, 97+%
| 0-00-0 |
|
4-(Diethylamino)salicylaldehyde, 98%
| 17754-90-4 |
|
3,3'-Diazido-Diphenylsulfone, 97%
| 75742-13-1 |
|
n-Methylethylamine hydrochloride, 99%
| 624-60-2 |
|
Triethylenemelamine, 98%
| 51-18-3 |
|
Exo-2-Bromo-5,5-Ethylenedioxy-Bicyclo ??2.2.1??Heptane-Syn-7-Carboxylic
| 65877-98-7 |
|
3-(Trimethylsilyl)-1-propanol, 97%
| 2917-47-7 |
|
4-Phenylimidazole, 99%
| 670-95-1 |
|
Ethyl phenylpropiolate, 98%
| 2216-94-6 |
|
4-Amino-2-butanol, 98%
| 39884-48-5 |
|
Diethyl p-aminobenzylphosphonate
| 20074-79-7 |
|
1,2-Cyclohexanedicarboxylic anhydride, cis and trans mixture, 98%
| 85-42-7 |
|
1,3,6,8-Pyrenetetrasulfonic Acid Tetra- Sodium Salt, 99% (UV-VIS)
| 59572-10-0 |
|
Tetraphenylene, 98%
| 212-74-8 |
|
5-Nitroanthranilonitrile, 99%
| 17420-30-3 |
|
2,2-Dichlorooctadecanoic acid, 90%
| 56279-50-6 |
|
[1,3-Bis(Diphenylphosphino)Propane]Nickel (II) Chloride
| 15629-92-2 |
|
1-Chloro-2,5-Dibromobenzene, 99+%
| 3460-24-0 |
|
1,8-Diamino-3,6-dioxaoctane, 98%
| 929-59-9 |
|
2-(1-Naphthylmethyl)-2-imidazoline hydrochloride, 99%
| 550-99-2 |
|
Monomethylviologen, 99% (titr.)
| |
|
3-Phenoxypropionic acid, 99%
| 7170-38-9 |
|
1-Heptanol, 98%
| 111-70-6 |
|
2,6-Dihydroxyanthraquinone ,94%
| 84-60-6 |
|
Ethyl Eosin (Potassium Salt)
| 6359-04-2 |
|
2-Hydroxypropyl methacrylate, stabilized with 0.11% MEHQ
| 923-26-2 |
|
Triphenylphosphine
| 603-35-0 |
|
o-Fluorophenylacetonitrile, 97%
| 326-62-5 |
|
1-(Trimethylsilyl)-1-propyne, 98%
| 6224-91-5 |
|
Tetraethylammonium Chloride Hydrate, 99%
| 56-34-8 |
|
Chromium (III) Sulfide, 99%
| 12018-22-3 |
|
Alpha-2-Chloroisodurene, 98%
| 1585-16-6 |
|
2-Amino-5-Nitrothiazole, 97%
| 121-66-4 |
|
3-Methyl-1-(4-sulfophenyl)-2-pyrazolin-5- one (pract), 98% (titr.)
| 89-36-1 |
|
|